Are you for real Sangi, I suppose it’s entertainment, listening to someone who’s not invested and is ready to gamble his pension on something he thinks is not what it is, unbelievable, I don’t believe it, get a proper job.
I get your point sangi, but look at it this way. They start with a desperate case , and do brain scans to see what’s going on, if all good they will add more patient’s as they go along. Tell me they did not say that!!!.
2 trials to be announced, Ms,Crohns , COVID, and maybe Alzheimer’s as foralumab has passed safety and optimum dosage stage. Phase 1 il6 mab tils501 What’s not to like!
Sangi If and I say if a fund raising does happen on excellent news of COVID trial it will only cost a few million shares, minimal dilution, more money at an SP of £3/£4, so stop whinging it’s not a problem. I’ve said enough on subject.
You will find a ‘catalyst’ is something that will get the sp moving like news ,or pivotal point in trials that are good, so no fundraising’s until 2022 as stated by Kunwar . Only catalyst ‘s to get sp moving again. You use a catalyst to get things moving!
The SPMS trial is the info FDA has asked for and by way of a PET? Scan we will see it actually working. All good to me . Trial is for 6 months but visual data should be available from start. Sangi you believe what you like.
Re iterated amazing results of COVID trial, there words, will work in all mutations and new virus’s that cause our body to kill itself, regulates T regs. And yes no time line for new trial so must assume all going ahead as and when possible.
Have asked for more info , which is a the secondary progressive ms trial, which they are now going to do, also they are going to brain scan the patient as they sniff the foralumab and we shall see it actually working!!!! WOW what film that’s gonna make. Alzheimer’s had good pre clinical so ahead we go. All within 6months ‘Tils style’ no probs. Good scan and we go fully into big trial in MS, or ‘ get bought out’ my opinion on buyout but stands to reason, not far to go before the realisation of big pharma will kick in.
Trade. They have done pre clinical so now they can go forward. They are very confident of success as data says foralumab will work in all similar indications ie MS ,ALS, Alzheimer’s etc, and also all COVID variations and new ones. All good to me.
Excellent conference. All progressing well. Pleased Alzheimer’s is underway, my main realisation was they were saying it all works and now have to prove it to the FDA which, of course, is very time consuming. All good for me.
We can’t be throttled forever, somethings got to blow, and we know they can’t say a lot ‘NDA’s’. Or can they, it’s all in public domain, just needs confirmation.